Acute Axon Damage and Demyelination are Mitigated by 4-Aminopyridine (4-AP) Therapy after Experimental Traumatic Brain Injury
Kryslaine L. Radomski, Xiaomei Zi, Fritz Walter Lischka, Mark Noble, Zygmunt Galdzicki, Regina C. Armstrong
This study tests 4-aminopyridine as an acute treatment for traumatic brain injury, finding it reduces axon damage and demyelination in preclinical models.
Acta Neuropathologica Communications · May 2, 2022Peer-reviewedNeuroscience